COEUS appoints Lee Termini to its board of directors.
July 8, 2020 – Devon, PA – COEUS, formerly COEUS Consulting Group, a leading healthcare communications, technology, talent, and consulting firm delivering a variety of services and platforms to all stakeholders in the healthcare ecosystem, today announced that Lee Termini has joined its Board of Directors. Mr. Termini, who was most recently President of MediMedia Managed Markets/ICON, was responsible for building MediMedia Managed Markets’ business in key pharmaceutical, biotech, and medical device companies. Lee is a proven leader with a strong track record of driving results, accelerating growth, and building shareholder value.
“Lee will be an excellent addition to the Coeus Holdings Board of Directors and his deep operational expertise and contacts in the industry will be highly valuable as the Coeus family of companies continue to grow,” said Marc Hixson, President & CEO at Coeus Holdings. “His experience in accelerating growth will be a tremendous asset as we execute our strategic plan.”
Mr. Termini is an accomplished executive with extensive experience executing strategy and building service companies within the life science space. Prior to working at MediMedia/ICON, Mr. Termini was Executive Director, Account Management, at Pasteur Mérieux Connaught (which then became Aventis Pasteur, now Sanofi-Aventis). As Executive Director, Lee directed the efforts for one of three business units and was responsible for sales, marketing, and contracting for the managed care marketplace for the world’s largest vaccine manufacturer. He started his pharmaceutical career at Stuart Pharmaceuticals (now AstraZeneca). Mr. Termini earned his bachelor’s degree from the University of Arizona.
“It’s an incredibly exciting time to join Coeus’ Board of Directors,” stated Mr. Termini. “Coeus has made tremendous progress in growing its expertise and service offerings within the market access space, and I look forward to contributing to its continued success.”
Established in 2009, COEUS is a leading healthcare consulting, communications, technology, and talent firm. The company offers clients a variety of services, as well as SaaS technology platforms, for various stakeholders throughout the healthcare ecosystem including all payers and emerging or more established drug manufacturers. Leveraging the deep knowledge and experience of the company’s many subject matter experts, COEUS works on all drug types with a particular focus on cell and gene therapies, rare diseases, and oncology. The company also has unique expertise in the creation and management of value-based agreements by leveraging COEBRA™, the company’s evidence and outcomes adjudication platform. In its 13-year history, the company has supported the launch of more than 120 pharmaceutical brands and has worked with more than 300 pharma clients including many top global pharmaceutical manufacturers. To learn more about COEUS and the company’s offerings, visit 1coeus.com.